AnaptysBio, Inc. (ANAB) Social Stream



AnaptysBio, Inc. (ANAB): $30.99

-0.12 (-0.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANAB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Anaptysbio Inc (ANAB) Price Targets From Analysts

Use the tables below to see what analysts covering Anaptysbio Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-26 6 $50 $25 $36 $31.11 15.72%
2021-11-08 6 $50 $19 $35 $31.11 12.5%

The Trend in the Analyst Price Target


ANAB's average price target has moved up $17.57 over the prior 19 months.

Over the past 44 weeks, ANAB's average upside potential has been 25.28%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-03-06 5 42 27 33.25 29.47 12.83%
2021-09-20 6 50 23 35.33 26.56 33.02%
2021-02-20 6 42 16 29.80 29.17 2.16%
2021-11-08 6 50 19 35.00 37.46 -6.57%
2021-04-10 4 42 19 28.50 20.87 36.56%

ANAB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 2 0 3 1 1 6

The Trend in the Broker Recommendations


Over the past 31 days, ANAB's average broker recommendation rating worsened by 0.1.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ANAB as an investment opportunity.

  • In terms of how Anaptysbio Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -75.55% of that group.
  • In terms of how Anaptysbio Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 10.65% of that group.
  • In the context of stocks in the mid market cap category, Anaptysbio Inc's number of analysts covering the stock is greater than 75.38% of them.
  • In the context of stocks in the mid market cap category, Anaptysbio Inc's average analyst price target is higher than 82.38% of them.

In the Pharmaceutical Products industry, AMTI, AMRX, and AMRN are the three stocks most similar to Anaptysbio Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ANAB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6173 seconds.